Sponsor pipeline

Jiangsu Hansoh Pharmaceutical Co., Ltd. clinical trial pipeline

Get alerts when Jiangsu Hansoh Pharmaceutical Co., Ltd.'s trials change

54 active trials 18 recruiting 10 Phase 3 20 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

  1. Minor
    2 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-28 NCT07844967 A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506 Phase 1 Recruiting
2026-09-23 NCT07836504 A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal… Phase 1 Not Yet Recruiting
2026-09-16 NCT07822542 A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without… Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
33
Phase 1/2
5
Phase 2
4
Phase 3
10
Phase 4
2

Active trials top 25 of 54

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06743438 Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB Hepatitis B, Chronic Active, Not Recruiting 2024-12-19
NCT05367765 A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients… CML, Chronic Phase Not Yet Recruiting 2022-05-10
Phase 3
NCT04951635 A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in… Non-small Cell Lung Cancer Recruiting 2022-06-16
NCT07822542 A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without… Carcinoma, Non-Small-Cell Lung Not Yet Recruiting 2026-09-16
NCT07759869 A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia SCHIZOPHRENIA 1 (Disorder) Not Yet Recruiting 2026-08-12
NCT07754123 Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With… Advanced or Metastatic NSCLC Not Yet Recruiting 2026-08-10
NCT07677384 A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder Insomnia Disorder Not Yet Recruiting 2026-06-30
NCT07587385 A Study of HS-10506 in Chinese Patients With Insomnia Disorder Insomnia Disorder Not Yet Recruiting 2026-05-14
NCT07156500 A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and… Type 2 Diabetes Not Yet Recruiting 2025-09-05
NCT07156539 A Phase 3 Study of HS-20094 in Patients With T2DM Type 2 Diabetes Not Yet Recruiting 2025-09-05
NCT04923906 Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or… Non-small Cell Lung Cancer Active, Not Recruiting 2024-11-25
NCT04687241 Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell… Non-small Cell Lung Cancer Active, Not Recruiting 2024-11-07
Phase 2
NCT06147570 A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small… Nonsmall Cell Lung Cancer Recruiting 2023-11-27
NCT07765628 A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With… Moderate to Severe Plaque Psoriasis Not Yet Recruiting 2026-08-14
NCT07555054 A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With… Chronic Kidney Disease Not Yet Recruiting 2026-04-28
NCT07474636 Efficacy and Safety Study of HS-10542 for IgA Nephropathy IgAN Not Yet Recruiting 2026-03-16
Phase 1/2
NCT07468851 A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are… High-risk Non-muscle-invasive Bladder Cancer Recruiting 2026-09-04
NCT07470762 Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal… Paroxysmal Nocturnal Hemoglobinuria Recruiting 2026-04-13
NCT07097935 Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma Advanced Clear Cell Renal Cell Carcinoma Recruiting 2025-08-01
NCT05435248 Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung… Advanced or Metastatic NSCLC Recruiting 2024-11-04
NCT06864507 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy… Chronic Spontaneous Urticaria Not Yet Recruiting 2025-03-07
Phase 1
NCT07844967 A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506 Hepatic Impairment (Moderate or Mild) & Normal Hepatic Function Recruiting 2026-09-28
NCT06461156 A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung… Locally Advanced or Metastatic NSCLC Recruiting 2026-08-31
NCT07130916 A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer Recruiting 2025-08-19
NCT06846710 Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118 Psoriasis Recruiting 2025-08-07
See all 54 active Jiangsu Hansoh Pharmaceutical Co., Ltd. trials with filters →

Disease areas by active trials, top 10 of 20

Non-Small Cell Lung Cancer (NSCLC) (15) · Lung Cancer (12) · Psoriasis (3) · Breast Cancer (2) · Chronic Myeloid Leukemia (CML) (2) · Colorectal Cancer (2) · Diabetes (2) · Kidney Cancer (2) · Obesity (2) · Ovarian Cancer (2)

Get alerts when Jiangsu Hansoh Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free